Hormone replacement therapy again. Risk-benefit relation differs between populations and individuals
- PMID: 9632398
- PMCID: PMC1113355
- DOI: 10.1136/bmj.316.7148.1842
Hormone replacement therapy again. Risk-benefit relation differs between populations and individuals
Comment on
-
Hormone replacement therapy and risk of hip fracture: population based case-control study. The Swedish Hip Fracture Study Group.BMJ. 1998 Jun 20;316(7148):1858-63. doi: 10.1136/bmj.316.7148.1858. BMJ. 1998. PMID: 9632404 Free PMC article.
References
-
- The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 1995;273:199–208. - PubMed
-
- Nactigall LE, Nachtigall RH, Rachtigall RD, Beckman EM. Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems. Obstet Gynecol. 1979;54:74–79. - PubMed
-
- Meade TW, Berra A. Hormone replacement therapy and cardiovascular disease. Br Med Bull. 1992;48:276. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources